elliot Servais to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications elliot Servais has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
1.328
-
Watkins AA, Rizvi TZ, Lopez E, Shehata D, Ssemaganda H, Lin Z, Stock CT, Moffatt-Bruce SD, Servais EL. Trends and comparative outcomes between operative approaches for segmentectomy in lung cancer. J Thorac Cardiovasc Surg. 2025 Mar; 169(3):745-752.e2.
Score: 0.828
-
Suaiti L, Sullivan TB, Rieger-Christ KM, Servais EL, Suzuki K, Burks EJ. Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma. Clin Lung Cancer. 2023 05; 24(3):e126-e133.
Score: 0.186
-
Towe CW, Servais EL, Grau-Sepulveda M, Kosinski AS, Brown LM, Broderick SM, Wormuth DW, Fernandez FG, Kozower BD, Raymond DP. Impact of Chest Wall Resection on Mortality After Lung Resection for Non-Small Cell Lung?Cancer. Ann Thorac Surg. 2022 12; 114(6):2023-2031.
Score: 0.173
-
Stiles BM, Servais EL, Lee PC, Port JL, Paul S, Altorki NK. Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging. J Thorac Cardiovasc Surg. 2009 Jan; 137(1):13-9.
Score: 0.071
-
Kachala SS, Servais EL, Park BJ, Rusch VW, Adusumilli PS. Therapeutic sentinel lymph node imaging. Semin Thorac Cardiovasc Surg. 2009; 21(4):327-38.
Score: 0.071